Pfizer Bids Adieu to Covid Boom Years

Market heard on the street COVID-19 fades financial gains, putting pressure on management to deliver new…

Moderna’s RSV Vaccine Reduces Risk of Respiratory Diseases, Study Finds

Health The company says the experimental shot was 83.7% effective against lower-respiratory diseases caused by RSV

Why Biotech Is Poised for a Recovery This Year

Market heard on the street Pharma and biotech stocks moved in opposite directions last year, but…

FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge Drugs

Health Wall Street Journal review finds agency oversteps trials to protect patients, ensures studies are properly…

AstraZeneca to Buy U.S. Cardiorenal-Drug Maker

For an initial $1.3 billion, the Anglo-Swedish company will acquire CinCor Pharma, including the rights to…

New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients

Health Medicare will not pay for a drug under a previously issued rule restricting use of…

China to allow rapid test to confirm Covid cases

World Asia China Beijing takes more steps to dismantle its zero-covid policies

China’s new mRNA COVID vaccine targeting Omicron begins trial production

Chinese drugmaker CanSino Biologics began trial production of a vaccine using mRNA technology to target the…

WSJ News Exclusive | Naloxone Startup Pursues FDA Approval for Over-the-Counter Swab

The FDA has encouraged companies to pursue nonprescription status for opioid-reversal drugs.

Crispr Gene-Editing Drugs Show Promise in Preliminary Study

Sept. 16, 2022 7:18 am ET Intellia Therapeutics Inc. reported encouraging early-stage study results for its…